Ahmet Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmet Yilmaz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Hasan Üstün
Kocaeli University, Faculty of Medicine, Department of Medical Oncology, Turkey
2 shared publications A. Borazan
Harpsundsvägen 9, 2tr 12458 Bandhagen/Stockholm Sweden Tel.: +46‐737705975
1 shared publicationAli Borazan
Kocaeli University Faculty of Medicine, Department of Medical Oncology1, Internal Medicine2, Karaman Tuberculosis Centre3, Turkey
1 shared publication- Ismail Biri
Koru Ankara Hosp, Dept Gen Surg, Ankara, Turkey
1 shared publication Nesrin Bilgiçli
Kocaeli University Faculty of Medicine, Department of Medical Oncology1, Internal Medicine2, Karaman Tuberculosis Centre3, Turkey
1 shared publication- Yücel Gültekin
Usak University, School of Medicine
1 shared publication
Latest Publications
- 24 May 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 32 (2) , 122-128
The Prognostic Factors on Survival Rates for Patients with Stage II-III Colon Cancer
- 24 May 2021
- Published by Galenos Yayinevi in Turkish Journal of Colorectal Disease
- Vol. 32 (2) , 122-128
The Prognostic Factors on Survival Rates for Patients with Stage II-III Colon Cancer
- Open Access
- 11 February 2004
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 58 (1) , 22-25
Diagnostic value of tumoural markers in pleural effusions
The aim was to reassess the diagnostic value of tumour markers such as carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9 and CA 72-4 in the pleural fluid of various diseases, both in benign and malignant. Eighty-one patients (41 malignant and 40 benign pleural effusion) were included in this study. The effusion levels of CEA, CA 15-3, CA 19-9 and CA 72-4 were assayed with commercial enzyme immunoassays. CEA, CA 15-3, CA 19-9 and CA 72-4 mean pleural effusion fluid levels in malignant group were found to be significantly higher than that in benign group, but CA 19-9 mean pleural effusion fluid levels of malignant and benign group were similar. It was of interest to evaluate the prediction of the origin by pleural tumour markers. In pleurisies with a negative cytology, these assays are particularly useful when the clinical presentation cannot clearly exclude an underlying malignancy.
- 11 February 2004
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 58 (1) , 22-25
Open AccessDiagnostic value of tumoural markers in pleural effusions
The aim was to reassess the diagnostic value of tumour markers such as carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, CA 19-9 and CA 72-4 in the pleural fluid of various diseases, both in benign and malignant. Eighty-one patients (41 malignant and 40 benign pleural effusion) were included in this study. The effusion levels of CEA, CA 15-3, CA 19-9 and CA 72-4 were assayed with commercial enzyme immunoassays. CEA, CA 15-3, CA 19-9 and CA 72-4 mean pleural effusion fluid levels in malignant group were found to be significantly higher than that in benign group, but CA 19-9 mean pleural effusion fluid levels of malignant and benign group were similar. It was of interest to evaluate the prediction of the origin by pleural tumour markers. In pleurisies with a negative cytology, these assays are particularly useful when the clinical presentation cannot clearly exclude an underlying malignancy.